/SHIV

Natalia Makarova1, Tyana Singletary1, M Melissa Peet2

  • 1Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 30329, United States.

PubMed
概括

用于预防艾滋病毒的新型局部插入剂,含有天诺福维尔阿拉芬胺烟酸 (TAF) 和埃尔维特格拉维尔 (EVG) 是有前途的. 这些插件在潜在暴露后使用时,可提供显著的暴露后保护,防止艾滋病毒感染.